KP Tissue Valuation
| KPTSF Stock | USD 7.49 0.07 0.93% |
At this time, the firm appears to be overvalued. KP Tissue owns a latest Real Value of $6.49 per share. The recent price of the firm is $7.49. Our model forecasts the value of KP Tissue from analyzing the firm fundamentals such as Current Valuation of 74.38 M, price to book of 1.24 X, and Shares Outstanding of 9.94 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that KP Tissue's price fluctuation is not too volatile at this time. Calculation of the real value of KP Tissue is based on 3 months time horizon. Increasing KP Tissue's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the KPTSF pink sheet is determined by what a typical buyer is willing to pay for full or partial control of KP Tissue. Since KP Tissue is currently traded on the exchange, buyers and sellers on that exchange determine the market value of KPTSF Pink Sheet. However, KP Tissue's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.49 | Real 6.49 | Hype 7.49 | Naive 7.34 |
The real value of KPTSF Pink Sheet, also known as its intrinsic value, is the underlying worth of KP Tissue Company, which is reflected in its stock price. It is based on KP Tissue's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of KP Tissue's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of KP Tissue helps investors to forecast how KPTSF pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of KP Tissue more accurately as focusing exclusively on KP Tissue's fundamentals will not take into account other important factors: KP Tissue Total Value Analysis
KP Tissue is now projected to have takeover price of 74.38 M with market capitalization of 76.14 M, debt of 0, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the KP Tissue fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
74.38 M | 76.14 M | 0 |
KP Tissue Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of KPTSF implies not a very effective usage of assets in December.KP Tissue Ownership Allocation
The market capitalization of KP Tissue is $76.14 Million. Around 81.11 % of KP Tissue outstanding shares are held by general public with 0.07 percent owned by insiders and only 18.82 (percent) by institutions. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.KP Tissue Profitability Analysis
Net Income was 1.24 M with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates KP Tissue's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in KP Tissue and how it compares across the competition.
About KP Tissue Valuation
The pink sheet valuation mechanism determines KP Tissue's current worth on a weekly basis. Our valuation model uses a comparative analysis of KP Tissue. We calculate exposure to KP Tissue's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of KP Tissue's related companies.KP Tissue Inc., through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. KP Tissue Inc. was incorporated in 2012 and is headquartered in Mississauga, Canada. Kp Tissue operates under Household Personal Products classification in the United States and is traded on OTC Exchange.
8 Steps to conduct KP Tissue's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates KP Tissue's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct KP Tissue's valuation analysis, follow these 8 steps:- Gather financial information: Obtain KP Tissue's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine KP Tissue's revenue streams: Identify KP Tissue's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research KP Tissue's industry and market trends, including the size of the market, growth rate, and competition.
- Establish KP Tissue's growth potential: Evaluate KP Tissue's management, business model, and growth potential.
- Determine KP Tissue's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate KP Tissue's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
KP Tissue Growth Indicators
Investing in growth stocks can be very risky. If the company such as KP Tissue does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 9.9 M | |
| Price Earnings Ratio | 85.1111 | |
| Quarterly Earnings Growth Y O Y | -0.202 | |
| Forward Price Earnings | 1000 | |
| Retained Earnings | -103.6 M | |
| Forward Annual Dividend Rate | 0.54 | |
| Shares Float | 9.9 M |
Complementary Tools for KPTSF Pink Sheet analysis
When running KP Tissue's price analysis, check to measure KP Tissue's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy KP Tissue is operating at the current time. Most of KP Tissue's value examination focuses on studying past and present price action to predict the probability of KP Tissue's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move KP Tissue's price. Additionally, you may evaluate how the addition of KP Tissue to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |